跳至主要内容
临床试验/CTRI/2021/03/031721
CTRI/2021/03/031721尚未招募未知

To evaluate the efficacy of combination of Dexamethasone and Spironolactone on the time to clinical recovery and freedom from supplemental oxygen dependence in COVID-19 patients.

one0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
one

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Confirmed COVID-19 by RT PCR test
  • Hospitalized Non ventilated patients with oxygen by mask or nasal prongs (WHO
  • Ordinal Scale 4: Appendix 1)
  • SpO2 < 94% on room air but maintaining SpO2 of >94% on VenturiMask / Non
  • rebreathing mask

排除标准

  • Participation in another clinical trial of an investigational medicinal product
  • Known hypersensitivity to the IMP
  • Significant electrolyte disturbance (Hyperkalemia: K+ >5.0 mmol/L)
  • Patient currently receiving potassium sparing diuretics that cannot be reasonably
  • Acute renal insufficiency
  • In the Investigatorâ??s opinion, patient is unwilling or unable to comply with drug
  • administration plan, laboratory tests or other study procedures.
  • Pregnant or lactating patient
  • Patients on the following drugs : ACE inhibitors, Amiloride, Hydrocortisone,
  • Prednisolone, Methylprednisolone, Triamterene

研究者

发起方
one

相似试验